Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

13-flag IPMS during Pt infection

ABSTRACT: affinity purification coupled mass spectrometry (AP-MS) identified TaHSP90 as a thermoregulatory Lr13-interacting proteins during Pt infection

INSTRUMENT(S):

ORGANISM(S): Triticum Aestivum (wheat)

TISSUE(S): Plant Cell, Leaf

DISEASE(S): Wheat Allergy

SUBMITTER: Xinhai Wang

LAB HEAD: Zaifeng Li

PROVIDER: PXD063307 | Pride | 2025-10-07

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	checksum.txt	Txt
	gaopu-12.index	Other
	gaopu-12.raw	Raw
	gaopu-2.index	Other
	gaopu-2.raw	Raw

Items per page:

1 - 5 of 7

Similar Datasets

Fusarium sp. PT strain:PT

Project description:Fusarium sp. isolate PT

| PRJNA737353 | ENA

Pt-seq unveils the genomic binding pattern of platinum-based drugs [Pt-seq]

Project description:Platinum-based drugs (Pt drugs) are widely used in cancer chemotherapy, yet their genome-wide DNA binding patterns remain incompletely understood. Here, we present Pt-seq, an antibody-assisted, genome-wide method for mapping Pt-DNA adducts at single-base resolution. By employing exo- and endo- nucleases to remove background DNA, Pt-seq enables highly robust and sensitive profiling of binding sites for cisplatin, oxaliplatin, lobaplatin, and a Pt(IV) complex. Using Pt-seq, we identified hundreds to a few thousand binding clusters that are 10-20 kb in length and highly consistent among different Pt drugs. Notably, these binding clusters predominantly localize to centromeric and rDNA regions. In cisplatin-resistant cells, we found significantly reduced binding within these regions, suggesting a potential role in drug resistance. Moreover, we found that de novo mutations in cancer cells can create novel binding sites for Pt drugs. Based on this, we demonstrated that ICR-191, an acridine orange compound capable of inducing G insertions, enhances cisplatin-DNA crosslinking and sensitizes cells to Pt drugs. Collectively, Pt-seq sensitively profiles Pt drug-DNA interactions and deepens our understanding of the genome-wide effect of chemotherapeutic drugs.

2025-02-13 | GSE289501 | GEO

Mapping PT modifications in bacteria

Project description:One microbial organism always contains multiple DNA modification systems as defense strategies or epigenetic controls. Here, we describe crosstalk between two distinct DNA modifications with different target sequence motif: DNA phosphorothioation (PT, GPSAAC/GPSTTC by DndACDE proteins) and N6-methyl-adenine methylation (m6A, G6mATC by Dam protein). By using a newly developed DNA modification sequencing method PT nick-seq, we found that half of PT modifications change from GAAC/GTTC to GATC sites after bacteria have lost Dam.

2020-05-21 | GSE135910 | GEO

Regulatory role of E3 ubiquitin ligase Smurf2 on transcriptional corepressor KAP1

Project description:An E3 ubiquitin ligase Smurf2 and transcriptional co-repressor KAP1 have been documented to play crucial roles in similar cellular pathways including cell cycle, DNA damage response, chromatin compaction, senescence and cell death. Smurf2 and KAP1, through regulation of these cellular processes either drive or suppress tumorigenesis. Studies till date confer Smurf2 with a dual role in carcinogenesis, an oncogene and a tumor suppressor, depending on the cellular context. However, the molecular mechanisms governing Smurf2 functions remain unclear. Furthermore, studies have demonstrated significantly altered KAP1 protein levels in many human malignancies, despite which, the mechanisms operating in and regulating KAP1 stability and activity are obscure. In this study, we obtained evidence which indicates a strong and dynamic association between Smurf2 and KAP1. We found that Smurf2 directly binds KAP1 through its C2, WW1 and HECT domains. Further mechanistic studies also revealed that Smurf2 multi(mono)ubiquitinates KAP1 in E3 ligase-dependent manner. Moreover, Smurf2 differentially alters KAP1 protein levels in different types of mammalian and cancer cells and tissues, and significantly alters KAP1 interactome. Based on these findings, we propose a mechanism to explain the dual role and differential regulation of Smurf2 on KAP1 in a cell-context dependent manner. Further investigations of the identified Smurf2/KAP1 module could potentially lead to development of new, more efficient diagnostics tools and treatment paradigms.

2022-04-07 | PXD029642 | Pride

PT-modified B12 probe and Non-PT-modified B34 probe pull-down with Salmonella enterica serovar Cerro 87 cell lysate

Project description:To capture proteins that exhibit differential binding with PT- and non-PT-modified DNA in vivo, we performed pull-down assays using biotinylated DNA probes and the cell lysate of S. enterica serovar Cerro 87 that contains the dndBCDE-dndFGH module. For these experiments, we used two 30 bp DNA probes, B12 and B34, which share the same DNA sequences but possess PT-modified 5’-GPSAAC-3’/5’-GPSTTC-3’ and non-PT-modified 5’-GAAC-3’/5’-GTTC-3’ motifs, respectively.

2022-02-26 | PXD031869 | Pride

PT extracts and PT metabolites by Bacteroides ovatus

Project description:PT ethanol extract and BO 24 h fermentation experiment.

2023-06-30 | MSV000092325 | MassIVE

Pisolithus tinctorius strain:Pt 004

Project description:Pisolithus tinctorius Pt 004 Resequencing

| PRJNA444323 | ENA

Pisolithus tinctorius strain:Pt 007

Project description:Pisolithus tinctorius Pt 007 Resequencing

| PRJNA444324 | ENA

Pisolithus microcarpus strain:Pt 014

Project description:Pisolithus microcarpus Pt 014 Resequencing